Shares of Opthea Limited (NASDAQ:OPT - Get Free Report) hit a new 52-week high during trading on Friday . The company traded as high as $6.30 and last traded at $5.92, with a volume of 61261 shares traded. The stock had previously closed at $5.71.
Analyst Ratings Changes
Several analysts have recently weighed in on the stock. Canaccord Genuity Group raised shares of Opthea to a "strong-buy" rating in a research note on Tuesday, December 17th. HC Wainwright reiterated a "buy" rating and issued a $12.00 target price on shares of Opthea in a report on Wednesday, January 29th.
Get Our Latest Stock Report on Opthea
Opthea Trading Down 3.6 %
The business's 50-day simple moving average is $4.05 and its 200 day simple moving average is $3.71.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. ABC Arbitrage SA bought a new stake in Opthea during the fourth quarter valued at about $40,000. Twin Lakes Capital Management LLC purchased a new stake in shares of Opthea during the third quarter valued at about $81,000. Finally, Jane Street Group LLC bought a new stake in shares of Opthea in the 3rd quarter valued at about $114,000. 55.95% of the stock is currently owned by hedge funds and other institutional investors.
About Opthea
(
Get Free Report)
Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Featured Stories
Before you consider Opthea, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Opthea wasn't on the list.
While Opthea currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
